1-5 of 5
Norbert Schmitz, M.D.
Close
Sort by
Journal Articles

Allogeneic Hematopoietic Cell Transplantation For Patients With Mycosis Fungoides and Sezary Syndrome: The Experience Of The EBMT Lymphoma Working Party With An Extended Five-Year Follow Up

Rafael F. Duarte, MD, PhD, Ariane Boumendil, PhD, Francesco Onida, MD, Ian H Gabriel, Dr, Reyes Arranz, MD, William Arcese, MD, Xavier Poire, MD, Guido Kobbe, MD, Franco Narni, MD, Agostino Cortelezzi, MD, Eduardo Olavarría, MD, Norbert Schmitz, M.D. Ph.D., Anna Sureda, MD, Peter Dreger, MD
Journal: Blood
Blood (2013) 122 (21): 2094.
https://doi.org/10.1182/blood.V122.21.2094.2094
Published: 2013
Journal Articles

Evaluation Of Myeloablative Therapy Followed By Autologous Stem Cell Transplantation In First Remission In Patients With Advanced Stage Follicular Lymphoma After Initial Immuno-Chemotherapy (R-CHOP) Or Chemotherapy Alone: Analysis Of 940 Patients Treated In Prospective Randomized Trials Of The German Low Grade Lymphoma Study Group (GLSG)

Wolfgang Hiddemann, M.D., Martin H. Dreyling, M.D. Ph.D., Bernd Metzner, M.D., Michael Pfreundschuh, M.D. Ph.D., Martin Wilhelm, M.D. Ph.D., Eva Lengfelder, M.D. Ph.D., Georg Hess, M.D. Ph.D., Michael Hallek, M.D. Ph.D., Norbert Schmitz, M.D. Ph.D., Christiane Pott, M.D. Ph.D., Thomas Fischer, M.D. Ph.D., Roswitha Forstpointner, M.D., Eva Hoster, Ph.D., Michael Unterhalt, M.D. Ph.D.
Journal: Blood
Blood (2013) 122 (21): 419.
https://doi.org/10.1182/blood.V122.21.419.419
Published: 2013
Journal Articles

Zanolimumab, a Fully Human Monoclonal Antibody: Preliminary Results of an Ongoing Clinical Trial in CD4 + Peripheral T-Cell Lymphomas (PTCL).

Francesco d’Amore, MD, Thomas Relander, M.D., Mats Jerkeman, M.D., Hans Hagberg, M.D., Anders Osterborg, M.D., Peter Johnson, M.D., John A. Radford, M.D., Barry W. Hancock, M.D., Martin Gramatzki, M.D., Norbert Schmitz, M.D., Herve Tilly, M.D, Franck Morschhauser, M.D., STeen Lisby, M.D, Ole Baadsgaard, M.D
Journal: Blood
Blood (2006) 108 (11): 2723.
https://doi.org/10.1182/blood.V108.11.2723.2723
Published: 2006
Journal Articles

Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Michael Pfreundschuh, MD, Marita Kloess, Samira Zeynalova, Eva Lengfelder, M.D., Astrid Franke, M.D., Marcel Reiser, M.D., Hjalmar Steinhauer, M.D., Michael Clemens, M.D., Christina Nickenig, M.D., Maike de Wit, M.D., Bernd Metzner, M.D., Manfred Hensel, M.D., Hans-Guenther Mergenthaler, M.D., Ruediger Liersch, M.D., Ulrich Duehrsen, M.D., Leopold Balleisen, M.D., Monika Engelhardt, M.D., Viola Poeschel, M.D., Joerg Schubert, M.D., Lorenz Truemper, M.D., Norbert Schmitz, M.D., Markus Loeffler, M.D.
Journal: Blood
Blood (2006) 108 (11): 205.
https://doi.org/10.1182/blood.V108.11.205.205
Published: 2006
Journal Articles

Dose-Dense Rituximab in Combination with Biweekly CHOP-14 for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Phase-I/II and Pharmacokinetic Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).

Viola Poeschel, MD, Maike Nickelsen, M.D., Mathias Hanel, M.D., Stephan Kremers, M.D., Swen Wessendorf, M.D., Hartmut Eimermacher, M.D., Norma Peter, M.D., Michael Wenger, M.D., Marcel Reiser, M.D., Norbert Schmitz, M.D., Michael Pfreundschuh, M.D.
Journal: Blood
Blood (2006) 108 (11): 2738.
https://doi.org/10.1182/blood.V108.11.2738.2738
Published: 2006